Wednesday, October 15, 2008

Wall Street Needs Muscle & Not Money Injection!

Many scientific studies show that when in crises and duress TESTOSTERONE will certainly decline . The evidence is strong in the scientific literature in Male studies mainly.

If Chairman Bernanke , SEC chairman Cox or Treasury Secretary Paulson would have their Testosterone (T) levels checked ( Total and free Testosterone). It is most is likely they will show as low. After treating thousands of men with Testosterone Therapy. I can easily spot those who are are low in T by their actions , movement and demeanor. All these guys are and many other financial experts of the world and Investors are most likely deeply depressed.

Testosterone ( T) is an excellent anti-depressant.Better than Prosac and others like it. Older ( Post menopausal) women can also benefit from small doses of T. Women need about 1 -3 mg whereas men usually need 50-100 mg T given via a gel like Testim , AndroGEl or Compounded T daily . Intramuscular T is more potent , but less convenient.

Too much T can lead to increased risk = Credit Debt Swaps. T levels highly likely have a close and tight correlation to the S&P and other standard Market indices. Those who have been shorting the Markets likely have higher T levels. Please go to your Doctor and get your T levels adjusted upward to survive the rough times still to come. Those who are thinking of "jumping off bridges" from Financial Losses really desperately need to have their Free & Total Testosterone levels checked and brought to a high normal levels if they have no prostate or other medical contraindications.

Make money by checking & Raising your Testosterone levels!

Best regards,

Karlis Ullis, MD

International Testosterone Expert

Santa Monica, CA 90403

kullis@ucla.edu

BTW: Investing in Testosterone Companies like the 3 month injection by Indevus, (IDEV). Shoud be FDA approved shortly. Auxillium (AUXL) = Testim or Repros pharm. in TX Androxal ( Similar to Clomiphene Citrate) in development stage 3 ( RPRX) may not be bad ideas.

No comments: